Genetic predispositions play a crucial role in shaping health outcomes, and one particular gene, FUT2 (fucosyltransferase 2), has gained attention for its wide-ranging implications. From autoimmune diseases to gut health and metabolic conditions, understanding FUT2 and its impact on health can provide deeper insights into disease susceptibility and targeted interventions.
FUT2 and Secretor Status: An Overview
The FUT2 gene determines a person’s secretor status, which reflects their ability to secrete blood group antigens into bodily fluids, including the gut. Individuals can be classified as secretors (those who have active FUT2 gene expression) or non-secretors (those with an inactive FUT2 gene). Secretor status influences various aspects of health, including microbiota composition, immune response, and disease risk.
Health Implications of FUT2 Variants
- Inflammatory and Autoimmune Diseases:
- Non-secretors have been found to experience a higher prevalence of low-level chronic infections, such as candida and strep, alongside autoimmune conditions like Crohn’s disease, rheumatoid arthritis, and psoriasis.
- The FUT2 gene plays a role in gut health by modulating the composition and function of the gut microbiota. Altered gut flora in non-secretors can contribute to dysbiosis and chronic inflammation, common in autoimmune diseases.
